CIK 0001604464
- Non-accelerated filer
- Smaller reporting company
Atara Biotherapeutics, Inc.
Sign in to watch- Ticker
- ATRA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460920988
- Phone
- +1 805-623-4211
- Business address
- 1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $999,994
- in 1 filing
- Open-market sales, last 90 days
- $39,368
- in 1 filing
Net +$960,625. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 3 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-10-13 | Ciechanover Isaac E. Chief Executive Officer | Sale | −2,400 | $15.91 | $38K | 404,178 |
| 2016-10-12 | MCGRATH JOHN Chief Financial Officer | Sale | −2,500 | $16.41 | $41K | 94,323 |
| 2016-10-11 | MCGRATH JOHN Chief Financial Officer | Sale | −2,500 | $18.52 | $46K | 96,823 |
| 2016-09-28 | Ciechanover Isaac E. Chief Executive Officer | Sale | −4,500 | $21.40 | $96K | 406,878 |
| 2016-09-28 | Ciechanover Isaac E. Chief Executive Officer | Sale | −300 | $21.82 | $7K | 406,578 |
| 2016-09-27 | Ciechanover Isaac E. Chief Executive Officer | Sale | −7,200 | $20.50 | $148K | 411,378 |
| 2016-09-22 | Turner Heather D VP, General Counsel & Sec. | Grant or award · Employee Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2016-09-22 | Haqq Christopher Chief Medical Officer | Grant or award | +90,000 | 383,948 | ||
| 2016-09-22 | Soffer Gad Chief Operating Officer | Grant or award | +90,000 | 235,249 | ||
| 2016-09-22 | Ciechanover Isaac E. Chief Executive Officer | Grant or award | +320,000 | 549,136 | ||
| 2016-09-16 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,600 | $19.32 | $70K | 418,578 |
| 2016-09-15 | Ciechanover Isaac E. Chief Executive Officer | Sale | −3,600 | $19.39 | $70K | 422,178 |
| 2016-08-23 | Ciechanover Isaac E. Chief Executive Officer | Sale | −4,800 | $22.08 | $106K | 425,778 |
| 2016-08-22 | Ciechanover Isaac E. Chief Executive Officer | Sale | −4,800 | $22.58 | $108K | 430,578 |
| 2016-08-16 | Soffer Gad Chief Operating Officer | Sale | −100 | $20.95 | $2K | 150,505 |
| 2016-08-16 | Soffer Gad Chief Operating Officer | Sale | −5,256 | $22.44 | $118K | 145,249 |
| 2016-08-15 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion | +7,211 | 90,970 | ||
| 2016-08-15 | Clark Mitchall G. Chief R & QA Officer | Exercise or conversion · Restricted Stock Unites | −7,211 | 48,077 | ||
| 2016-08-15 | Fust Matthew K Director | Exercise or conversion | +1,603 | 15,491 | ||
| 2016-08-15 | Fust Matthew K Director | Exercise or conversion · Restricted Stock Units | −1,603 | 10,149 |
Page 51 of 71 · 1,403 trades